CVI Investments, Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:17 pm Sale |
2024-09-30 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 40,000 1.900% |
-133,913 (-77.00%) |
Filing |
| 2024-09-16 10:22 am Purchase |
2024-09-11 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 173,913 8.500% |
173,913 (New Position) |
Filing |